Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoNo recent work listed

Honglin Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5193-6309; OpenAlex author ID A5101820003. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism. Co-author DOI 10.1053/j.gastro.2021.09.066↗
  2. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. Co-author DOI 10.1172/jci136760↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eric Andrew Collisson · 2 shared papers, 2020–2022 · strength 0.26
  2. Zhen J. Wang · 1 shared paper, 2020 · strength 0.08
  3. Wilko Weichert · 1 shared paper, 2020 · strength 0.08
  4. Robert J. Torphy · 1 shared paper, 2020 · strength 0.08
  5. Jen Jen Yeh · 1 shared paper, 2020 · strength 0.08
  6. Valerie Marie Weaver · 1 shared paper, 2020 · strength 0.08
  7. Michael Anthony Hollingsworth · 1 shared paper, 2020 · strength 0.08
  8. Michael Jon Pishvaian · 1 shared paper, 2020 · strength 0.08
  9. Margaret A. Tempero · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.